InvestorsHub Logo
Followers 399
Posts 86391
Boards Moderated 2
Alias Born 02/05/2004

Re: TeamTOC post# 21817

Tuesday, 11/17/2020 10:53:34 AM

Tuesday, November 17, 2020 10:53:34 AM

Post# of 27839
VBIV has something that VXRT does not and that is IMO a huge drug about to hit the market. Their current HepB drug is way better than the competition and will be the standard of care IMO.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.